InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Thompson Jaye. Insider active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 7 reports have been published. Breakdown: 7 buys · 0 sell. Total volume traded: €74k. Activity tracked since 13 January 2022. The latest transaction was disclosed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
500 shares@ US$16.740.0021% mcap10.5% of flowCommon StockSEC:0001493152-22-010484:0
Ideal exit: 14 Jan 2023 (T+270)
500 shares@ US$18.470.0022% mcap11.2% of flowCommon StockSEC:0001493152-22-002817:0
Ideal exit: 28 Oct 2022 (T+270)
500 shares@ US$18.470.0022% mcap25.1% of flowCommon StockSEC:0001493152-22-002817
Ideal exit: 28 Oct 2022 (T+270)
500 shares@ US$16.330.0019% mcap9.8% of flowCommon StockSEC:0001493152-22-002021:0
Ideal exit: 18 Oct 2022 (T+270)
500 shares@ US$16.330.0019% mcap21.9% of flowCommon StockSEC:0001493152-22-002021
Ideal exit: 18 Oct 2022 (T+270)
1,000 shares@ US$19.990.0046% mcap53.0% of flowCommon StockSEC:0001493152-22-001189
Ideal exit: 10 Oct 2022 (T+270)
1,000 shares@ US$19.990.0046% mcap23.7% of flowCommon StockSEC:0001493152-22-001189:0
Ideal exit: 10 Oct 2022 (T+270)
7 of 7 declarations
About Thompson Jaye
Jaye Thompson is a director at Greenwich LifeSciences, Inc.
